Identification of Genes Controlling Senescence in Human Epithelial Cells Role i...
Identification of Genes Controlling Senescence in Human Epithelial Cells Role in Cancer
Cellular senescence was originally described as the cell cycle arrest that accompanies the exhaustion of replicative potential in cultured primary mammalian cells. Whereas ‘replicative’ senescence is triggered by telomere erosion,...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
SAF2010-18829
INVISTIGACION DE MECANISMOS COMUNES SOBRE CANCER Y ENVEJECIM...
169K€
Cerrado
P63 PROSTUMOR
Investigating the role of p63 in PROstate STem cells and tUM...
100K€
Cerrado
SAF2013-49082-P
INVESTIGANDO MECANISMOS COMUNES EN CANCER Y ENVEJECIMIENTO.
242K€
Cerrado
MODELING SENESCENCE
Generation of mouse models for the study of cellular senesce...
100K€
Cerrado
BFU2008-00559
PAPEL DEL NRF-2 EN LA REGULACION DE LA SENESCENCIA CELULAR,...
36K€
Cerrado
CANCER&AGEING
COMMOM MECHANISMS UNDERLYING CANCER AND AGEING
2M€
Cerrado
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Cellular senescence was originally described as the cell cycle arrest that accompanies the exhaustion of replicative potential in cultured primary mammalian cells. Whereas ‘replicative’ senescence is triggered by telomere erosion, other stimuli such as activated oncogenes, oxidative stress, DNA damage and sub-optimal culture conditions can also induce a senescent phenotype called ‘premature’ senescence or ‘stasis’. Senescence acts as a potent antitumor mechanism. Malignant transformation occurs after the bypass of senescence caused by mutations in oncogenes and tumour suppressors. Thus, novel genes linked with oncogenesis can be isolated by identifying genes regulating senescence. As the majority of solid tumours arise from cells of epithelial origin, the aim of the current project is to identify genes controlling senescence in epithelial cells. Specifically, human prostate epithelial cells (HprECs) will be studied as the corresponding prostate cancer represents the most frequent cancer amongst men. A genetic screening for senescence bypass will be performed in these cells using a retroviral shRNA library. The validated genes will be prioritized thanks to a parallel microarray based-analysis of transcriptional changes associated with senescence in HPrECs and to existing databases that evaluate expression profiles in human tumours. The expression of the relevant candidates will be then confirmed in a wider and independent subset of clinical tumour samples using tissue micro-array. Finally, the oncogenic properties of the candidate genes will be analysed in several models of tumourigenesis. Overall, the investigation described here aims at using senescence as a system to identify novel tumour suppressor genes.